论文部分内容阅读
目的观察前列泰胶囊治疗慢性前列腺增生的临床疗效。方法将160例慢性前列腺增生症患者随机分为治疗组和对照组,每组各80例。治疗组采用前列泰胶囊进行治疗;对照组采用普乐安片治疗,两组治疗均为4周1个疗程,治疗3个疗程。结果两组治疗前、后患者的国际前列腺症状评分(IPSS)、最大尿流率(Qmax)、生活质量评分(QOL)等指标均有显著性差异(P<0.01);两组治疗后的各疗效指标比较,差异显著(P<0.05),疗效优于普乐安片。结论前列泰胶囊能明显改善慢性前列腺增生患者的症状评分,改善患者的生活质量。
Objective To observe the clinical efficacy of Qianlietai Capsule in the treatment of chronic prostatic hyperplasia. Methods 160 patients with chronic benign prostatic hyperplasia were randomly divided into treatment group and control group, 80 cases in each group. The treatment group was treated with Qianlietai capsule. The control group was treated with Puleanan tablets. The two groups were treated with 1 course of treatment for 4 weeks and 3 courses of treatment. Results The scores of International Prostate Symptom Score (IPSS), Qmax and QOL in both groups before and after treatment were significantly different (P <0.01). After treatment, Efficacy indicators, the difference was significant (P <0.05), the effect is superior to Pu Luan tablets. Conclusions Qianlietai capsules can significantly improve the symptom scores of patients with chronic prostatic hyperplasia, improve the quality of life of patients.